Clinical Trial Update: Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine [Phase 4]

View source ↗

Summary

Phase IV trial update on immunogenicity and safety of the EV71 vaccine for Hand, Foot and Mouth Disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (enterovirus 71 vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: COMPLETED